Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
13.42
-0.05 (-0.37%)
At close: Aug 4, 2026, 4:00 PM EDT
12.17
-1.25 (-9.31%)
Pre-market: Aug 5, 2026, 8:26 AM EDT
Bioventus Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 581.85 | 568.09 | 573.28 | 512.35 | 512.12 | 430.9 | |
Revenue Growth | 3.14% | -0.91% | 11.89% | 0.04% | 18.85% | 34.17% |
Cost of Revenue | 182.4 | 179.93 | 185.05 | 184.15 | 181.04 | 128.19 |
Gross Profit | 399.45 | 388.16 | 388.23 | 328.19 | 331.08 | 302.71 |
Selling, General & Admin | 322.48 | 314.03 | 343.8 | 303.88 | 332.13 | 254.25 |
Research & Development | 11.57 | 12.11 | 13.95 | 13.45 | 23.85 | 19.04 |
Other Operating Expenses | -0 | 2.32 | 38.02 | 83.75 | 132.58 | 8.99 |
Total Operating Expenses | 334.05 | 328.46 | 395.77 | 401.08 | 488.57 | 282.28 |
Operating Income | 58.28 | 53.98 | -15.2 | -81.73 | -167.23 | 12.06 |
Interest Expense | -19.88 | -26.49 | -38.79 | -40.68 | -12.02 | -1.11 |
Other Non-Operating Income (Expense) | -0.6 | -27.14 | -38.79 | -40.68 | -12.02 | -1.11 |
Total Non-Operating Income (Expense) | -20.47 | -53.62 | -77.58 | -81.35 | -24.04 | -2.22 |
Pretax Income | 38.64 | 25.71 | -52.34 | -121.11 | -189.03 | 9.49 |
Provision for Income Taxes | -22.84 | -1.57 | -5.29 | 0.09 | -44.37 | -1.97 |
Net Income | 61.48 | 54.55 | -94.1 | -316.82 | -358.04 | 21.04 |
Minority Interest in Earnings | 4.45 | 4.54 | -10.92 | -39.4 | -54.69 | -9.79 |
Earnings From Discontinued Operations | - | - | - | 74.43 | 68.74 | 1.87 |
Net Income to Common | 54.46 | 22.73 | -36.13 | -156.23 | -158.7 | 19.38 |
Net Income Growth | - | - | - | - | - | 18.06% |
Shares Outstanding (Basic) | 67 | 67 | 65 | 63 | 61 | 45 |
Shares Outstanding (Diluted) | 70 | 69 | 65 | 63 | 61 | 45 |
Shares Change | 5.16% | 6.77% | 3.03% | 2.05% | 35.00% | -11.70% |
EPS (Basic) | 0.81 | 0.34 | -0.56 | -2.49 | -2.59 | -0.15 |
EPS (Diluted) | 0.77 | 0.33 | -0.56 | -2.49 | -2.59 | -0.15 |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | 94.29 | 72.11 | 37.79 | 7.98 | -15.02 | 9.47 |
Free Cash Flow Growth | 176.51% | 90.83% | 373.43% | - | - | -82.85% |
Free Cash Flow Per Share | 1.35 | 1.05 | 0.59 | 0.13 | -0.24 | 0.21 |
Gross Margin | 68.65% | 68.33% | 67.72% | 64.06% | 64.65% | 70.25% |
Operating Margin | 10.02% | 9.50% | -2.65% | -15.95% | -32.66% | 2.80% |
Profit Margin | 10.57% | 9.60% | -16.41% | -61.84% | -69.91% | 4.88% |
FCF Margin | 16.20% | 12.69% | 6.59% | 1.56% | -2.93% | 2.20% |
EBITDA | 103.53 | 100.99 | 34.36 | -24.36 | -111.84 | 46.94 |
EBITDA Margin | 17.79% | 17.78% | 5.99% | -4.75% | -21.84% | 10.89% |
EBIT | 58.28 | 53.98 | -15.2 | -81.73 | -167.23 | 12.06 |
EBIT Margin | 10.02% | 9.50% | -2.65% | -15.95% | -32.66% | 2.80% |
Effective Tax Rate | -59.10% | -6.09% | 10.11% | -0.07% | 23.48% | -20.72% |